Peter A. Egormin

1.7k total citations
14 papers, 1.3k citations indexed

About

Peter A. Egormin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Aging. According to data from OpenAlex, Peter A. Egormin has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Aging. Recurrent topics in Peter A. Egormin's work include Metabolism, Diabetes, and Cancer (9 papers), FOXO transcription factor regulation (4 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Peter A. Egormin is often cited by papers focused on Metabolism, Diabetes, and Cancer (9 papers), FOXO transcription factor regulation (4 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Peter A. Egormin collaborates with scholars based in Russia, Germany and United States. Peter A. Egormin's co-authors include Irina G. Popovich, Vladimir N. Anisimov, Tatiana S. Piskunova, Mark A. Zabezhinski, Anna V. Semenchenko, Lev M. Berstein, И. Г. Коваленко, Margarita L. Tyndyk, M. N. Yurova and Francesca Re and has published in prestigious journals such as Annals of the New York Academy of Sciences, The International Journal of Biochemistry & Cell Biology and Cell Cycle.

In The Last Decade

Peter A. Egormin

14 papers receiving 1.2k citations

Peers

Peter A. Egormin

PHYSI

AGING

SURGE

ONCOL

И. Г. Коваленко Russia

M. N. Yurova Russia

Tatiana S. Piskunova Russia

Dongyin Guan United States

Emma L. Baar United States

Theresa M. Ward United States

Katharine Brown United States

Diana M. Willmes Germany

Anna Cederberg Sweden

Bong‐Hyun Ahn South Korea

И. Г. Коваленко Russia

Peter A. Egormin

610 ×0.8

360 ×0.8

PHYSI

296 ×0.8

AGING

183 ×0.8

SURGE

179 ×0.8

ONCOL

Citations per year, relative to Peter A. Egormin Peter A. Egormin (= 1×) peers И. Г. Коваленко

Countries citing papers authored by Peter A. Egormin

Since Specialization

Citations

This map shows the geographic impact of Peter A. Egormin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Egormin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Egormin more than expected).

Fields of papers citing papers by Peter A. Egormin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Egormin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Egormin. The network helps show where Peter A. Egormin may publish in the future.

Co-authorship network of co-authors of Peter A. Egormin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Egormin. A scholar is included among the top collaborators of Peter A. Egormin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Egormin. Peter A. Egormin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Popovich, Irina G., et al.. (2018). [Prospects of use of antidiabetic biguanides for cancer prevention and treatment: results of preclinical studies].. PubMed. 62(2). 234–44. 2 indexed citations

Anisimov, Vladimir N., Irina G. Popovich, Mark A. Zabezhinski, et al.. (2016). Polyphenolic drug composition based on benzenepolycarboxylic acids (BP-C3) increases life span and inhibits spontaneous tumorigenesis in female SHR mice. Aging. 8(9). 1866–1875. 10 indexed citations

Panchenko, Andrey, M. N. Yurova, Peter A. Egormin, et al.. (2015). [Age dynamics of angiogenesis markers in transgenic HER-2/neu (FBV/N) mammary adenocarcinoma-prone mice].. PubMed. 61(4). 642–6. 1 indexed citations

Panchenko, Andrey, Irina G. Popovich, Peter A. Egormin, et al.. (2015). Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice. Biogerontology. 17(2). 317–324. 19 indexed citations

Anisimov, Vladimir N., Irina G. Popovich, Mark A. Zabezhinski, et al.. (2014). Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin. Cell Cycle. 14(1). 46–55. 38 indexed citations

Anisimov, Vladimir N., Mark A. Zabezhinski, Irina G. Popovich, et al.. (2011). Rodent models for the preclinical evaluation of drugs suitable for pharmacological intervention in aging. Expert Opinion on Drug Discovery. 7(1). 85–95. 9 indexed citations

Anisimov, Vladimir N., Lev M. Berstein, Irina G. Popovich, et al.. (2011). If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging. 3(2). 148–157. 220 indexed citations

Anisimov, Vladimir N., Peter A. Egormin, Tatiana S. Piskunova, et al.. (2010). Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle. 9(1). 188–197. 142 indexed citations

Anisimov, Vladimir N., Tatiana S. Piskunova, Irina G. Popovich, et al.. (2010). Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice. Aging. 2(12). 945–958. 102 indexed citations

10.

Anisimov, Vladimir N., Lev M. Berstein, Peter A. Egormin, et al.. (2008). Metformin slows down aging and extends life span of female SHR mice. Cell Cycle. 7(17). 2769–2773. 273 indexed citations

11.

Anisimov, Vladimir N., et al.. (2005). Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice. Bulletin of Experimental Biology and Medicine. 139(6). 721–723. 77 indexed citations

12.

Anisimov, Vladimir N., Lev M. Berstein, Peter A. Egormin, et al.. (2005). Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Experimental Gerontology. 40(8-9). 685–693. 324 indexed citations

13.

Anisimov, Vladimir N., Lev M. Berstein, Irina G. Popovich, et al.. (2005). Central and Peripheral Effects of Insulin/IGF‐1 Signaling in Aging and Cancer: Antidiabetic Drugs as Geroprotectors and Anticarcinogens. Annals of the New York Academy of Sciences. 1057(1). 220–234. 16 indexed citations

14.

Popovich, Irina G., Mark A. Zabezhinski, Peter A. Egormin, et al.. (2004). Insulin in aging and cancer: antidiabetic drug diabenol as geroprotector and anticarcinogen. The International Journal of Biochemistry & Cell Biology. 37(5). 1117–1129. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact